(Q40134350)

17 September 2017

title

In vitro models of TGF-beta-induced fibrosis suitable for high-throughput screening of antifibrotic agents (English)

1 reference

17 September 2017

5

1 reference

17 September 2017

Qihe Xu

1

1 reference

17 September 2017

Jill T Norman

series ordinal

2

1 reference

17 September 2017

Shashi Shrivastav

series ordinal

3

1 reference

17 September 2017

Javier Lucio-Cazana

series ordinal

4

1 reference

17 September 2017

publication date

9 May 2007

1 reference

American Journal of Physiology - Renal Physiology

17 September 2017

published in

1 reference

17 September 2017

volume

293

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

F631-40

1 reference

Induction of nodular sclerosis by insulin in rat mesangial cells in vitro: studies of collagen

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

21 January 2018

TGF-beta and fibrosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Anti-TGF-beta strategies for the treatment of chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Medical treatment for pulmonary fibrosis: current trends, concepts, and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Systems biology in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Smad3 as a mediator of the fibrotic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Isolation and characterization of Chinese hamster ovary cell variants defective in adhesion to fibronectin-coated collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Scleroderma, fibroblasts, signaling, and excessive extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

High-throughput target discovery using cell-based genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Antagonism of transforming growth factor-Beta signaling inhibits fibrosis-related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Renal fibrosis: new insights into the pathogenesis and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Human renal mesangial cells are a target for the anti-inflammatory action of 9-cis retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Tranilast and hypertensive heart disease: further insights into mechanisms of an anti-inflammatory and anti-fibrotic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Tranilast inhibits the proliferation of uterine leiomyoma cells in vitro through G1 arrest associated with the induction of p21(waf1) and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Stable cell lines of T-SV40 immortalized human glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

The impact of tranilast on restenosis after coronary angioplasty: the Second Tranilast Restenosis Following Angioplasty Trial (TREAT-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Fibrotic disease and the T(H)1/T(H)2 paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

Development of TGF-beta signalling inhibitors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00379.2006

10.1152/AJPRENAL.00379.2006

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference